|Sun Pharma Advanced Research Company Limited|
Sun Pharma Advanced Research Centre
India - Map
Sun Pharma Advanced Research Company Limited, a pharmaceutical company, is engaged in research and development of drugs and delivery systems. The company develops products in oncology, ophthalmology, CNS, respiratory areas. It develops Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia; Sun 0597, a topical glucocorticoid for the treatment of allergic rhinitis, asthma, and other applications; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. The company also offers Baclofen GRS for the treatment of spasticity; Wrap Matrix controlled release systems, including Levetiracetam ER for epilepsy and Venlafaxine ER for depression; Paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; and Docetaxel injection concentrate for nanodispersion. In addition, it provides Somatostain analogues are used to treat acromegaly and growth hormone dependent cancers; BKC- free Latanoprost and Latanoprost + Timolol used for the treatment for glaucoma; and Fluticasone + Salmeterol DPI for the treatment of asthma. The company operates in India and internationally. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.
|Mr. Dilip Shantilal Shanghvi ,
Chairman and Managing Director
|Mr. Anil Raghavan ,
Chief Exec. Officer
|Ms. Meetal S. Sampat ,
Compliance Officer and Company Sec.
|Dr. Subhas Bhowmick ,
VP of R&D (Formulation)
|Dr. K. Shivramchandra ,
VP of R&D (Analytical Devel.)
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in INR.|